In 2011, we wrote about risks to the global economy, and concluded investors were being too enthusiastic about riding the liquidity train.
We advocated a ‘capital preservation mode’, which prompted our holdings in GlaxoSmithKline, British American Tobacco, and Diageo. We continued to fret through the autumn, when high class names within the FTSE 100 outperformed. Price risk was the subject at hand then, and it remains so now. We bought William Hill back in 2009, when the market showed no interest in the business. Now it is a darling of the City, nestling comfortably in the FTSE 100. BAE Systems, also hitherto unloved, has flourished this year. GlaxoSmithKline, Restaurant Group and Tarsus are high quality businesses th...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes